Tscan Therapeutics Inc - TCRX - stock price prediction, stock price target, analyst ratings from 8 analysts

Tscan Therapeutics Inc has a share price target of US$ 9, revenue growth forecast of 108.5%, and profit growth estimate of -15.6% for FY25, based on top 8 analyst calls.